Elucidating the specific pharmacological mechanism of action (MOA) of naturally occurring compounds can be challenging. While Tarselli et al. (60) designed the initial de novo synthetic pathway to conolidine and showcased this naturally transpiring compound proficiently suppresses responses to the two chemically induced and inflammation-derived pain, the pharmacologic target https://brooksjknok.dsiblogger.com/70681953/a-review-of-alternative-natural-pain-relief-to-replace-traditional-painkillers